Literature DB >> 24421702

Azithromycin use in paediatrics: A practical overview.

Philippe Ovetchkine, Michael J Rieder.   

Abstract

Azithromycin is an antibiotic that is commonly prescribed for upper and lower respiratory tract infections in children. While it has proven benefits, some concerns regarding azithromycin use have arisen in recent years. This practice point considers azithromycin therapy for acute respiratory infections in otherwise healthy children. Pharmacokinetics, spectrum of activity, the problem of resistant bacteria and clinical aspects are considered, along with recommendations for use and contraindications. Azithromycin should be avoided in patients with a significant risk of bacteremia. It is associated with pneumococcal resistance and, with stated exceptions, is generally not recommended for the treatment of acute pharyngitis, acute otitis media or pneumococcal community-acquired pneumonia in the paediatric population.

Entities:  

Keywords:  Antibiotics; Infections; Macrolides; Resistance; Treatment

Year:  2013        PMID: 24421702      PMCID: PMC3680256     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  24 in total

1.  Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?

Authors:  F Baquero
Journal:  J Chemother       Date:  1999-02       Impact factor: 1.714

2.  Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-20021).

Authors:  R R Reinert
Journal:  J Chemother       Date:  2004-12       Impact factor: 1.714

3.  A comparison of antibiotic use in children between Canada and Denmark.

Authors:  Fawziah Marra; Dominique L Monnet; David M Patrick; Mei Chong; Christian T Brandt; Meghan Winters; Margit S Kaltoft; Gregory J Tyrrell; Marguerite Lovgren; William R Bowie
Journal:  Ann Pharmacother       Date:  2007-03-20       Impact factor: 3.154

4.  Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.

Authors:  M A Kelley; D J Weber; P Gilligan; M S Cohen
Journal:  Clin Infect Dis       Date:  2000-10-13       Impact factor: 9.079

5.  Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14.

Authors:  Ricardo Dias; Manuela Caniça
Journal:  J Antimicrob Chemother       Date:  2004-11-05       Impact factor: 5.790

6.  Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media.

Authors:  R Dagan; C E Johnson; S McLinn; N Abughali; J Feris; E Leibovitz; D J Burch; M R Jacobs
Journal:  Pediatr Infect Dis J       Date:  2000-02       Impact factor: 2.129

Review 7.  Diagnosis and management of acute otitis media.

Authors: 
Journal:  Pediatrics       Date:  2004-05       Impact factor: 7.124

8.  Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience.

Authors:  Pierre Alex Crisinel; Isabelle Chevalier; Fabien Rallu; Bruce Tapiero; Valérie Lamarre; Roseline Thibault; Philippe Ovetchkine
Journal:  Eur J Pediatr       Date:  2010-05-22       Impact factor: 3.183

9.  Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006.

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Natalie Chui; Jessica Minion; Sipi Garg; James D Kellner; Thomas J Marrie
Journal:  Vaccine       Date:  2009-04-18       Impact factor: 3.641

Review 10.  Hidden epidemic of macrolide-resistant pneumococci.

Authors:  Keith P Klugman; John R Lonks
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  2 in total

1.  Intestinal microbiome analysis demonstrates azithromycin post-treatment effects improve when combined with lactulose.

Authors:  Elpiniki Nikolaou; Elena Kamilari; Dragana Savkov; Artemy Sergeev; Irina Zakharova; Paris Vogazianos; Marios Tomazou; Athos Antoniades; Christos Shammas
Journal:  World J Pediatr       Date:  2019-10-03       Impact factor: 2.764

Review 2.  Antibiotic susceptibility among non-clinical Escherichia coli as a marker of antibiotic pressure in Peru (2009-2019): one health approach.

Authors:  Angie K Castillo; Kathya Espinoza; Antony F Chaves; Fernando Guibert; Joaquim Ruiz; Maria J Pons
Journal:  Heliyon       Date:  2022-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.